Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to -$2.4 million.

  • Journey Medical's Free Cash Flow fell 10596.37% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.9 million, marking a year-over-year increase of 8589.27%. This contributed to the annual value of -$24.1 million for FY2024, which is 1015291.67% down from last year.
  • According to the latest figures from Q3 2025, Journey Medical's Free Cash Flow is -$2.4 million, which was down 10596.37% from -$942000.0 recorded in Q2 2025.
  • Journey Medical's Free Cash Flow's 5-year high stood at $18.7 million during Q3 2023, with a 5-year trough of -$19.1 million in Q1 2022.
  • For the 5-year period, Journey Medical's Free Cash Flow averaged around -$2.7 million, with its median value being -$3.2 million (2021).
  • Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 150455.55% in 2022, then skyrocketed by 35744.3% in 2023.
  • Journey Medical's Free Cash Flow (Quarter) stood at -$3.2 million in 2021, then dropped by 19.65% to -$3.8 million in 2022, then crashed by 330.66% to -$16.5 million in 2023, then surged by 113.47% to $2.2 million in 2024, then plummeted by 207.1% to -$2.4 million in 2025.
  • Its last three reported values are -$2.4 million in Q3 2025, -$942000.0 for Q2 2025, and -$2.8 million during Q1 2025.